VEGFA and age-related macular degeneration: Of note, Josifova et al. found that when Ocufolin forte was added to standard AMD therapy, there was a larger reduction in retinal venous pressure (RVP) and homocysteine, resulting in a decreased frequency of anti-VEGF injections [17].